Taxpayers fund a YUGE percentage of the R&D costs for drugs – either through tax breaks to Big Pharma or outright grants.* It’s pretty clear to me that we taxpayers should own the patents on the drugs that we have paid to develop.
* Which is how Big Pharma is able, as mentioned in the article, to pay out to their greedy executives and shareholders more money than the profits they take in from sales of grossly overpriced drugs.
Medicare for all, not a public option.
Extremely important issue - for which reason it will not even come close to being implemented any time soon - be it a Don or a ByDon adminstration.
Which drug lords do us more harm?
To date “public option” is where universal medical insurance discussions go to die.
As Zed has been pointing out all of those agreements entered into at the international level, from the free trade deals to the WTO and GATS are there by design so as to prevent individual Countries from going this route.
Now Countries do have the right to withdraw from said treaties but they were implemented in the first place so as to keep these things in private hands as a means of generating profits for the investor class. What keeps Countries from doing this is the 1 percent who will not give up such a money making venture and want to ensure they are the ones profiting of this.
It not just Big Pharma we have to take on. It the entire system called Capitalism.
It’s worth noting Zed’s comments in the Commons during the past month, concerning the insidious for-profit demands of the GATS treaty: Capitalism in control of all aspects of commerce and services.
That explains the convoluted creature that is Affordable Care Act. “Affordable.” That’s the campaign rallying cry of our young congresswoman, Abby F, and Senate candidate Theresa G, who was recruited to run by Chuck Schumer.
You in Canada are fortunate to have your public system of health care. May you protect it. Its easy access is featured in the Michael Moore documentary, Sicko, in Detroiter’s driving over the bridge to Windsor for their health care. In contrast, we have to make it complicated, and of course expensive, in the US.
Medicare for All in the US? Probably not in my lifetime. I’m still pulling for it.
The headline seems to be misleading. The article isn’t about adding a public option to the insurance market place. It seems to be suggesting that we need publicly owned pharmaceutical organizations that research, develop and deliver directly to the public.
That is a good idea, we can’t have the drugs made in China either. Any idiot can see that in a crises we are putting ourselves at risk by bad policy decisions that benefit the few not the many.
The feds could negotiate bulk purchases from pharma manufacturers at low prices. Seems like the most practical solution for letting pharma do what it handles well (mfg and distribution) while lowering prices for infectious disease meds.
Why do the proponents of government-controlled medicine never seem to realize that the same corrupt Congress which takes more dirty money from pharma than any other ‘contributor’ is going to create and control the programs?
About 20% of GDP in USA is spent on healthcare split about evenly between paying for drugs and paying for deciding which drug or drugs to administer to which patient or patients.
This is as close as it gets but I think the US is very strongly against it.
This is also relevant. But the US has opposed it for decades.
Are you refering to the Reasonable Pricing Rule that we dumped in 1995?
It limited the profits on drugs that had been funded by the US taxpayer, but we’re a different country than we were before the WTO.
Now we get away with charging more the more horrible the deasese is, even if its really cheap or almost free to make. We have changed our ideology to be - bluntly, its evil. 30 million poor people died of AIDS because of this. When it would have cost practically nothing to save their lives. Finanly an Indian firm made those drugs and sold them for around a thousad times less. But now were fighting to make it the way it was before again.